"Designing Growth Strategies is in our DNA"

Beta Thalassemia Testing Market Size, Share, and COVID-19 Impact Analysis, By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, and Others), By Test Type (Genetic Testing, Prenatal Testing, and Others), By Setting (Laboratories and Point of Care), By End-user (Hospitals & Clinics, Clinical Laboratories, and Others), and Regional Forecast, 2024-2032

Region :Global | Report ID: FBI107739 | Status : Ongoing



Beta thalassemia is defined as a blood disorder that results in the reduced production of hemoglobin. The condition is caused by a mutation in the hemoglobin beta (HBB) gene. This can lead to delayed growth, enlarged spleen and kidneys, diabetes, and other problems. People affected by beta thalassemia generally suffer from reduced oxygen levels in the body due to low hemoglobin levels.

Beta thalassemia testing kits are used for early diagnosis of abnormalities in blood cells and CBC (complete blood count) in patients. These tests are also used in prenatal testing and newborn screening to check for any genetic abnormalities.

Beta thalassemia traits are more common among people from Mediterranean countries and Asian, African, and Middle East countries. The rising population among these regions is primarily responsible for the increased demand for beta thalassemia testing. The increasing prevalence of the condition worldwide and the rising migration among people in different countries have fueled the demand for beta thalassemia testing in hospitals and diagnostic centers.

  • For instance, as per the article published by News-Medical.Net in March 2023, beta thalassemia is the most common form among populations of Mediterranean, African, and South Asian ancestry. Moreover, thalassemia affects approximately 4.4 out of every 10,000 live births worldwide.

Moreover, the increasing awareness among the population of genetic disorders and prenatal testing increases the demand for beta thalassemia testing.

Impact of COVID-19 on the Beta Thalassemia Testing Market

The global beta thalassemia testing market experienced a decline due to the outbreak of COVID-19. The decline was experienced as lockdown restrictions were imposed to control the spread of the virus resulting in postponing of diagnostic tests.

  • For instance, according to a research article published in the Journal of Medical Genetics 2020, there was a hindrance reported due to COVID-19 in accessing genetic testing blood draws, as a result of which genetic testing was tremendously impacted, wherein a reduction in genetic testing from 97.7% to 74.1% was observed during the pandemic.

Additionally, the decreased rate of tests in laboratories other than COVID-19 infection and the closure of labs and diagnostic centers all over the globe led to a decline in the beta thalassemia testing market.

However, the market experienced a significant recovery in 2021 due to the release of the lockdown and increased diagnosis and treatment of thalassemia among patients.

Key Insights

The report will cover the following key insights:

  • Prevalence of Beta Thalassemia, by Key Countries/Regions, 2022.

  • New Product Launches by Key Players.

  • Key Industry Developments by Key Players (Mergers, Acquisitions, Collaborations, etc.).

  • Impact of COVID-19 on the Market.

Analysis by Test Type

On the basis of test type, prenatal testing is expected to grow at a significant CAGR. Factors such as early detection in prenatal and postnatal diagnosis, direct examination of beta trait thalassemia, and low chances of infection have been fueling the segment's growth during the forecast period.

Moreover, genetic testing for beta thalassemia is anticipated to grow at a substantial CAGR. The increasing research in genetic tests for beta thalassemia and new product launches by key players has fueled the segment growth.

  • For instance, in February 2022, according to an article published by S. Karger AG, the method of analyzing Cell-Free Fetal DNA (cff-DNA) in maternal plasma by Digital PCR is efficient for prenatal diagnosis of beta-thalassemia.

Regional Analysis

To gain extensive insights into the market, Request for Customization

North America is anticipated to account for a significant share of the global beta thalassemia testing market. The primary factor responsible for the largest share in the market is the increasing incidence of beta thalassemia. The increased demand for testing and the presence of key market players such as Thermo Fisher Scientific Inc. and Bio-Rad Laboratories, Inc. is expected to drive the market in the region.

  • According to the National Center for Biotechnology Information (NCBI), December 2020, in the U.S. prevalence of beta thalassemia has increased by approximately 7.5% over the last 50 years due to an increase in immigration from Asian countries in the past decades.

Moreover, Asia Pacific is expected to grow at a significant CAGR due to rising prevalence of beta thalassemia cases in the region, increased immigration among different population groups and new product launches.

Key Players Covered

The report will include the profiles of key players such as MedGenome, TRUPCR, Bio-Rad Laboratories, Inc., ViennaLab Diagnostics GmbH, Thermo Fisher Scientific Inc., PerkinElmer Inc, Asper Biogene, BGI, Tosoh Bioscience, Inc., Mapmygenome, and others.


By Technology

By Test Type

By Setting

By End-user

By Geography

  • Next-Generation Sequencing

  • Polymerase Chain Reaction

  • Others

  • Prenatal Testing

  • Genetic Testing

  • Others

  • Laboratories

  • Point of Care

  • Hospitals & Clinics

  • Clinical Laboratories

  • Others

  • North America (U.S. and Canada)

  • Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of APAC)

  • Latin America (Brazil, Mexico, and the Rest of LATAM)

  • Middle East & Africa (GCC, South Africa, the Rest of MEA)

Key Industry Developments

  • September 2022: BGI announced the CE-IVDD certification for its thalassemia gene detection kit, a NGS technology used for genetic diagnosis in patients.

  • September 2022: BGI and the Azerbaijan Thalassemia Center announced a collaboration agreement, further aiming to improve thalassemia screening in Azerbaijan through genetic technology.

  • April 2022: BGI’s wholly owned subsidiary, Huada Biotechnology Co., Ltd, obtained the medical device registration certificate from the National Drug Administration for its alpha and beta thalassemia gene detection kit.

  • November 2020: Bio-Rad Laboratories, Inc., announced the introduction of new features of its D-10 hemoglobin testing system for better patient result management, optimized quality control, and offering fully automated beta thalassemia testing on a single platform.

  • Ongoing
  • 2023
  • 2019-2022

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients


Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.